9 research outputs found
Ribosomal Route to Small-Molecule Diversity
The cyanobactin ribosomal peptide (RP) natural product
pathway
was manipulated to incorporate multiple tandem mutations and non-proteinogenic
amino acids, using eight heterologous components simultaneously expressed
in Escherichia coli. These studies
reveal the potential of RPs for the rational synthesis of complex,
new small molecules over multiple-step biosynthetic pathways using
simple genetic engineering
Schematic representation of the draft mitochondrial genome of <i>L. patella</i> animal L2 (top, to scale).
<p>The hive plots <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0095850#pone.0095850-Krzywinski1" target="_blank">[61]</a> at the bottom of the figure show that the L2 assembly is syntenic with contigs assembled of the mitochondrial genomes of L5 and L6. In these plots, protein-coding genes are represented as circles, and contig boundaries are represented as zigzag lines. Homologous genes are joined by curved lines colored according to the sequence identity of the gene relevant gene pair. Abbreviations: COX, cytochrome <i>c</i> oxidase; NADH, nicotinamide adenine dinucleotide dehydrogenase.</p
Collection locations, phylogeny and divergence of <i>Lissoclinum patella</i> individuals collected across areas of the Southeastern Pacific between 2002 and 2011.
<p>(a) Collection sites, with a portion of the phylogenetic tree based on mitochondrial cytochrome c oxidase 1 (COXI) genes overlaid, with individuals colored by clades that diverge by 5% or more in their nucleotide sequence, as shown in (b).</p
Phylogenetic tree of 18S rRNA nucleotide sequences from our collected <i>L. patella</i> animals and other Didemnidae, with <i>Ciona intestinalis</i> acting as an outgroup.
<p>Phylogenetic tree of 18S rRNA nucleotide sequences from our collected <i>L. patella</i> animals and other Didemnidae, with <i>Ciona intestinalis</i> acting as an outgroup.</p
Heatmap and hierarchical clustering of select secondary metabolite peak volumes in LCMS runs on <i>L. patella</i> extracts (top left).
<p>Clustering based on secondary metabolites that are produced by the symbiotic bacteria <i>Prochloron didemni</i> and <i>Ca.</i> Endolissoclinum faulkneri closely follows the hosts' phylogeny as determined by COXI sequences (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0095850#pone-0095850-g002" target="_blank">Fig. 2</a>). The <i>P. didemni</i> compounds shown are all cyanobactins produced either by a patellamide-type pathway (red), or a trunkamide-type pathway (blue). These two types of are closely related ribosomal pathways that are highly tolerant to changes in the precursor peptide sequence. The patellazoles (magenta) are produced by another symbiont, <i>Candidatus</i> Endolissoclinum faulkneri, by a polyketide synthase pathway.</p
Phylogenetic tree of mitochondrial cytochrome <i>c</i> oxidase 1 (COXI) protein sequences from Didemnidae animals not included in Figure S3.
<p>The COXI sequences for <i>L. patella</i> amimals L2, L5 and L6 used to make this tree were obtained from the respective mitochondrial genome assembly from Illumina sequencing data. The inset identity matrix shows the pairwise nucleotide identities of sequences in this clade, indicating that <i>L. patella</i> sequence AB602781.1 likely is a group B animal.</p
Phylogenetic tree of mitochondrial cytochrome <i>c</i> oxidase 1 (COXI) protein sequences from our collected <i>L. patella</i> animals and other Didemnidae, with <i>Ciona savignyi</i> acting as the outgroup.
<p>Note: the <i>Didemnum vexillum</i> clade is collapsed for space. The Didemnidae COXI genes found in the NCBI database cover two non-overlapping regions of the gene (see Main Text), and therefore two separate trees were constructed (for the other tree, see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0095850#pone-0095850-g004" target="_blank">Figure 4</a>).</p
Genome-Directed Lead Discovery: Biosynthesis, Structure Elucidation, and Biological Evaluation of Two Families of Polyene Macrolactams against <i>Trypanosoma brucei</i>
Marine natural products are an important
source of lead compounds
against many pathogenic targets. Herein, we report the discovery of
lobosamides A–C from a marine actinobacterium, <i>Micromonospora</i> sp., representing three new members of a small but growing family
of bacterially produced polyene macrolactams. The lobosamides display
growth inhibitory activity against the protozoan parasite <i>Trypanosoma brucei</i> (lobosamide A IC<sub>50</sub> = 0.8 ÎĽM),
the causative agent of human African trypanosomiasis (HAT). The biosynthetic
gene cluster of the lobosamides was sequenced and suggests a conserved
cluster organization among the 26-membered macrolactams. While determination
of the relative and absolute configurations of many members of this
family is lacking, the absolute configurations of the lobosamides
were deduced using a combination of chemical modification, detailed
spectroscopic analysis, and bioinformatics. We implemented a “molecules-to-genes-to-molecules”
approach to determine the prevalence of similar clusters in other
bacteria, which led to the discovery of two additional macrolactams,
mirilactams A and B from <i>Actinosynnema mirum</i>. These
additional analogs have allowed us to identify specific structure–activity
relationships that contribute to the antitrypanosomal activity of
this class. This approach illustrates the power of combining chemical
analysis and genomics in the discovery and characterization of natural
products as new lead compounds for neglected disease targets